PubRank

B Lindgren

Author PubWeight™ 51.90‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Rosette-formation between human lymphocytes and sheep red cells not involving immunoglobulin receptors. Int Arch Allergy Appl Immunol 1970 5.92
2 Staging of bronchiolitis obliterans syndrome using home spirometry. Chest 1999 1.86
3 Validity of parental report of a child's medical history in otitis media research. Am J Epidemiol 1994 1.75
4 Informal and formal care among single-living elderly in Europe. Health Econ 2008 1.73
5 EuroQol: health-related quality of life measurement. Results of the Swedish questionnaire exercise. Health Policy 1991 1.61
6 Community acquired Pseudomonas aeruginosa urinary tract infection in preschool children. Pediatr Nephrol 1997 1.41
7 Your next of kin or your own career? Caring and working among the 50+ of Europe. J Health Econ 2007 1.17
8 Five common fallacies in estimating the economic gains of early discharge. Soc Sci Med Med Econ 1980 1.17
9 The economic impact of asthma and chronic obstructive pulmonary disease (COPD) in Sweden in 1980 and 1991. Respir Med 2000 1.16
10 Monitoring progress after lung transplantation from home-patient adherence. J Med Eng Technol 1997 1.06
11 Determining risk for chronic otitis media with effusion. Pediatr Infect Dis J 1988 1.04
12 What determines the costs of repair and rehabilitation of flexor tendon injuries in zone II? A multiple regression analysis of data from southern Sweden. J Hand Surg Br 2003 1.04
13 Diabetes, healthcare cost and loss of productivity in Sweden 1987 and 2005--a register-based approach. Diabet Med 2009 1.03
14 Variation in the degree and costs of adaptive phenotypic plasticity among Rana temporaria populations. J Evol Biol 2004 1.01
15 Direct costs of stroke for a Swedish population. Int J Technol Assess Health Care 1990 1.01
16 Changes in the costs of elective cholecystectomies, 1955-1965-1975. Ann Surg 1979 0.96
17 The family study of otitis media: design and disease and risk factor profiles. Genet Epidemiol 1996 0.95
18 Costs of on-demand and prophylactic treatment for severe haemophilia in Norway and Sweden. Haemophilia 2004 0.93
19 Cognitive deficits in iron-deficient and iron-deficient anemic children. J Pediatr 1986 0.92
20 Cost of sick leave for total hip replacement. Acta Orthop Scand 1988 0.90
21 Human insulin-like growth-factor-binding protein. Low-molecular-mass form: protein sequence and cDNA cloning. Eur J Biochem 1989 0.90
22 Injury to the human median and ulnar nerves in the forearm--analysis of costs for treatment and rehabilitation of 69 patients in southern Sweden. J Hand Surg Br 2005 0.89
23 Reliability and validity of spirometry measurements in a paperless home monitoring diary program for lung transplantation. Heart Lung 1994 0.88
24 The economics of general thromboembolic prophylaxis. World J Surg 1988 0.87
25 Productivity growth in health-care delivery. Med Care 1997 0.85
26 Knowledge and attitudes about otitis media risk: implications for prevention. Pediatrics 1997 0.85
27 Are there any positive consequences of childhood cancer? A review of the literature. Acta Oncol 2008 0.85
28 On-demand vs. prophylactic treatment for severe haemophilia in Norway and Sweden: differences in treatment characteristics and outcome. Haemophilia 2003 0.84
29 Facilitators and barriers to adherence with home monitoring using electronic spirometry. AACN Clin Issues 2001 0.84
30 How far does prophylaxis against infection in total joint replacement offset its cost? Br Med J (Clin Res Ed) 1988 0.84
31 Polymorphisms in the base excision repair pathway and graft-versus-host disease. Leukemia 2010 0.84
32 An economic and sociological interpretation of social differences in health-related behaviour: an encounter as a guide to social epidemiology. Soc Sci Med 1996 0.82
33 Diagnostic criteria for screening headache patients for temporomandibular disorders. Headache 1995 0.82
34 Screening for scoliosis. A cost-effectiveness analysis. Spine (Phila Pa 1976) 1990 0.82
35 The family as the health producer--when spouses are Nash-bargainers. J Health Econ 2001 0.82
36 Prospective study of tympanic membrane retraction, hearing loss, and multifrequency tympanometry. Otolaryngol Head Neck Surg 1999 0.81
37 Comparison of two teaching strategies: adherence to a home monitoring program. Clin Nurs Res 1996 0.80
38 Replantation-revascularization and primary amputation in major hand injuries. Resources spent on treatment and the indirect costs of sick leave in Sweden. J Hand Surg Br 1996 0.80
39 Regulation of IGFBP-1 in humans. Prog Growth Factor Res 1995 0.79
40 Hearing preservation after acoustic neuroma surgery. Skull Base Surg 2000 0.79
41 On individual preferences and aggregation in economic evaluation in healthcare. Pharmacoeconomics 2001 0.78
42 On the use of diazepam and pro-diazepam (2-benzoyl-4-chloro-N-methyl-N-lysylglycin anilide), as adjunct antidotes in the treatment of organophosphorus intoxication in the guinea-pig. J Pharm Pharmacol 1990 0.78
43 The cost-effectiveness of prevention of post-operative thromboembolism. Acta Chir Scand Suppl 1990 0.78
44 Economic costs of spontaneous pneumothorax. Chest 1991 0.77
45 Ultrasonographic screening for abdominal aortic aneurysm: analysis of surgical decisions for cost-effectiveness. World J Surg 1989 0.77
46 Comparison of the cost of preventing postoperative deep vein thrombosis with either unfractionated or low molecular weight heparin. Br J Surg 1996 0.77
47 IGFBP-1. Production and control mechanisms. Acta Endocrinol (Copenh) 1991 0.77
48 Willingness to pay for on-demand and prophylactic treatment for severe haemophilia in Sweden. Haemophilia 2004 0.76
49 Clinical outcome and health care costs in renal revascularization--percutaneous transluminal renal angioplasty versus reconstructive surgery. Br J Surg 1991 0.76
50 Testicular germ cell loss in children with renal failure. Pediatr Pathol 1989 0.76
51 Cost-effectiveness of simvastatin versus cholestyramine: results for Sweden. Pharmacoeconomics 1992 0.75
52 [How does one organize general practice in hospital outpatient clinics?]. Lakartidningen 1969 0.75
53 Standards for the cost-benefit approach to vascular surgery. Acta Chir Scand Suppl 1990 0.75
54 [Renovascular hypertension. Percutaneous angioplasty versus vascular reconstructive surgery--health-economics aspects]. Lakartidningen 1991 0.75
55 The effect of definitive irradiation on local control and disease free survival in breast cancer. Int J Radiat Oncol Biol Phys 1986 0.75
56 [Cessation of smoking decreases the number of cases with spontaneous pneumothorax and resources can be redistributed]. Lakartidningen 1989 0.75
57 [Water fluoridation--collective solution to an individual problem?]. Tandlakartidningen 1981 0.75
58 Routine operative cholangiography or pre-operative infusion cholangiography at elective cholecystectomy--a cost-effectiveness analysis. Acta Chir Scand 1987 0.75
59 Subsidizing pharmaceutical prescriptions: the experience of Denmark, Finland, Norway and Sweden. Soc Sci Med 1985 0.75
60 [Vaccines today and tomorrow. Cost benefit of vaccination--methods and examples]. Lakartidningen 1989 0.75
61 [Indication for fixation-treatment in marginal periodontitis. Comments to Hilding Björn's paper in No. 4, 1966]. Sver Tandlakarforb Tidn 1966 0.75
62 Randomized trial of the efficacy of trimethoprim-sulfamethoxazole and prednisone in preventing post-tympanostomy tube morbidity. Pediatr Infect Dis J 1995 0.75
63 [A new model for geriatric psychiatric care makes rapid intervention possible--5 years' data]. Lakartidningen 1989 0.75
64 Resolution of otitis media with effusion with the use of a stepped treatment regimen of trimethoprim-sulfamethoxazole and prednisone. Pediatr Infect Dis J 1991 0.75
65 The role of radiation therapy in Hodgkin disease: experience and controversy. The 54th annual Janeway Lecture: 1989. Cancer 1992 0.75
66 Changes in hospital costs for an appendectomy: 1955, 1965, and 1975. Am J Surg 1983 0.75
67 Assessing the role of adjuvant radiation therapy in the treatment of breast cancer. Int J Radiat Oncol Biol Phys 1988 0.75
68 Economic evaluation: what are we looking for and how do we get there? Haemophilia 2004 0.75
69 Decisions about treatment of aortoiliac claudication: the current practice among Swedish vascular surgeons. Eur J Surg 1997 0.75
70 [Joggers are usually healthy]. Lakartidningen 2000 0.75
71 Asthma and allergy: the significance of chronic conditions for individual health behaviour. Allergy 2002 0.75
72 [Unique "occupational disease"--asbestos among safe blowers]. Lakartidningen 1974 0.75
73 The choice of strategy in the treatment of intermittent claudication--a decision tree approach. Eur J Vasc Surg 1993 0.75
74 [Report from an NLV course in general practice]. Lakartidningen 1973 0.75
75 [Can studies on health economics be done without any requirements?]. Lakartidningen 1995 0.75
76 [Treatment of marginal periodontitis with fixed partial restorations--a thing of the past?]. Sver Tandlakarforb Tidn 1966 0.75
77 The cost-effectiveness of early or delayed surgery in acute cholecystitis. World J Surg 1985 0.75
78 Ligand blot analysis: validation of quantitative capabilities and utilization for measurement of truncated insulin-like growth factor regulation of Hep-G2 insulin-like growth factor binding protein-1 production. Anal Biochem 1993 0.75
79 Use of the Swedish microcomputer alarm system in care for the elderly and disabled. Policy and practice. Int J Technol Assess Health Care 1994 0.75
80 The consensus statements on adjuvant chemotherapy in breast cancer. Fact or artifact. Am J Clin Oncol 1988 0.75
81 [Indications for gingivectomy. A short comment on Hilding Björn's article in no. 23, 1967]. Sver Tandlakarforb Tidn 1968 0.75
82 [Economic gains of early discharge: 5 common fallacies]. Lakartidningen 1979 0.75
83 Comparison of therapeutic interchange with standard educational tools for influencing fluoroquinolone prescribing. Am J Health Syst Pharm 2001 0.75